Clinical Trial

A Trial to Compare the Amount of Centanafadine That Enters the Bloodstream for Two Different Formulations of Centanafadine

Name: A Trial to Compare the Amount of Centanafadine That Enters the Bloodstream for Two Different Formulations of Centanafadine — clinical trial record (NCT07465731)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this trial is to assess relative bioavailability of centanafadine (CTN) SR tablet to CTN QD XR capsule in healthy adult participants.

Trial Details

NCT Number	NCT07465731
Lead Sponsor	Otsuka Pharmaceutical Development & Commercialization, Inc.
Conditions	Healthy Volunteers
Enrollment	62 participants
Start Date	2022-10-27
Primary Completion	2023-03-26 (estimated)
Study Completion	2023-03-26 (estimated)
Updated on ClinicalTrials.gov	2026-03-12